menu
MENU
Contact Us
Menu
Introduction
Team & Board of Director
Partners
Investors
Latest News
Overview
Intranasal Vaccines
Asthma Immunotherapy
Respiratory Antiviral Immunotherapy
Contact us
Financial Reports
M.O.P.S. #6709
2025 Annual Report
2026-04-30
Events & Imformations
Updates
《Journal of Microbiology, Immunology and Infection》A detoxified E. coli heat-labile toxin LTh( α K) as a mucosal immunomodulator against acute respiratory viral infection
2026-09-25
